SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets
2007

SIRAC: A New Algorithm for Identifying Chromosomal Aberrations in Cancer

Sample size: 67 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lai Carmen, Horlings Hugo M, van de Vijver Marc J, van Beers Eric H, Nederlof Petra M, Wessels Lodewyk F A, Reinders Marcel J T

Primary Institution: Delft University, The Netherlands

Hypothesis

Can a supervised algorithm improve the identification of chromosomal aberrations in aCGH datasets?

Conclusion

The SIRAC algorithm effectively identifies chromosomal aberrations specific to cancer subtypes, showing improved results compared to previous methods.

Supporting Evidence

  • The SIRAC algorithm does not require preprocessing of aCGH datasets.
  • It identifies regions of chromosomal alteration that are specific to the problem of interest.
  • The results on breast cancer datasets align with previous findings.
  • The algorithm shows improved sensitivity and specificity for detecting chromosomal aberrations.
  • Using different window sizes enhances the detection of both small and large amplifications.
  • The method allows for a systematic evaluation of genomic regions without prior assumptions.
  • Results indicate that SIRAC can be applied to various aCGH platforms.
  • The algorithm's performance can be adjusted by changing the false discovery rate.

Takeaway

The SIRAC algorithm helps find important changes in DNA that can lead to cancer, making it easier for doctors to understand and treat the disease.

Methodology

The SIRAC algorithm uses a supervised approach to analyze aCGH data without preprocessing, focusing on relevant DNA-probes to identify regions of chromosomal alteration.

Potential Biases

Potential bias may arise from the choice of parameters and the specific datasets used for validation.

Limitations

The algorithm's performance may vary based on the chosen false discovery rate and the number of relevant DNA-probes selected.

Participant Demographics

The study involved 67 breast cancer patients from two datasets.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2105-8-422

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication